Venter Pharma And NovaMedica Sign Agreement To Commercialize New Lactose Intolerance Test In Russia

MADRID & MOSCOW--(BUSINESS WIRE)--NovaMedica LLC, a Russian pharmaceutical company, and Venter Pharma SL, a Spanish company, developing innovative diagnostic systems, have signed a partnership agreement that grants NovaMedica exclusive rights to commercialize a new technology for the diagnosis of lactose intolerance, LacTEST®, in Russia and the Community of Independent States (CIS).

Help employers find you! Check out all the jobs and post your resume.